These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26632708)

  • 1. Nonadherence of Oral Antihyperglycemic Medication Will Increase Risk of End-Stage Renal Disease.
    Chang PY; Chien LN; Lin YF; Chiou HY; Chiu WT
    Medicine (Baltimore); 2015 Nov; 94(47):e2051. PubMed ID: 26632708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Metformin Use With End-Stage Renal Disease in Patients With Type 2 Diabetes Mellitus: A Nationwide Cohort Study Under the Pay-for-Performance Program.
    Lee MC; Lee CH; Chang LY; Chang CH; Zhang JF; Lee MR; Wang JY; Chen SM
    J Clin Pharmacol; 2019 Nov; 59(11):1443-1452. PubMed ID: 31163098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Waist circumference and end-stage renal disease based on glycaemic status: National Health Insurance Service data 2009-2018.
    Cho YK; Huh JH; Moon S; Kim YJ; Kim YH; Han KD; Kang JG; Lee SJ; Ihm SH
    J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):585-595. PubMed ID: 36564188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extreme Levels of HbA1c Increase Incident ESRD Risk in Chinese Patients with Type 2 Diabetes: Competing Risk Analysis in National Cohort of Taiwan Diabetes Study.
    Liao LN; Li CI; Liu CS; Huang CC; Lin WY; Chiang JH; Lin CC; Li TC
    PLoS One; 2015; 10(6):e0130828. PubMed ID: 26098901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe Hypoglycemia as a Predictor of End-Stage Renal Disease in Type 2 Diabetes: A National Cohort Study.
    Lee YL; Yen SJ; Shin SJ; Huang YC; He JS; Lin KD
    Int J Environ Res Public Health; 2019 Feb; 16(5):. PubMed ID: 30813549
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypoglycemia-Related Hospitalizations and Mortality Among Patients With Diabetes Transitioning to Dialysis.
    Rhee CM; Kovesdy CP; You AS; Sim JJ; Soohoo M; Streja E; Molnar MZ; Amin AN; Abbott K; Nguyen DV; Kalantar-Zadeh K
    Am J Kidney Dis; 2018 Nov; 72(5):701-710. PubMed ID: 30037725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Vascular Adhesion Protein-1 Predicts End-Stage Renal Disease in Patients with Type 2 Diabetes.
    Li HY; Lin HA; Nien FJ; Wu VC; Jiang YD; Chang TJ; Kao HL; Lin MS; Wei JN; Lin CH; Shih SR; Hung CS; Chuang LM
    PLoS One; 2016; 11(2):e0147981. PubMed ID: 26845338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study on the impact of poor medication adherence on health status and medical expense for diabetes mellitus patients in Taiwan: A longitudinal panel data analysis.
    Lin CS; Khan H; Chang RY; Liao WC; Chen YH; Siao SY; Hsieh TF
    Medicine (Baltimore); 2020 Jun; 99(26):e20800. PubMed ID: 32590763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of end-stage renal disease associated with gout: a nationwide population study.
    Yu KH; Kuo CF; Luo SF; See LC; Chou IJ; Chang HC; Chiou MJ
    Arthritis Res Ther; 2012 Apr; 14(2):R83. PubMed ID: 22513212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visit-to-Visit Glucose Variability Predicts the Development of End-Stage Renal Disease in Type 2 Diabetes: 10-Year Follow-Up of Taiwan Diabetes Study.
    Yang YF; Li TC; Li CI; Liu CS; Lin WY; Yang SY; Chiang JH; Huang CC; Sung FC; Lin CC
    Medicine (Baltimore); 2015 Nov; 94(44):e1804. PubMed ID: 26554779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to antihypertensive agents improves risk reduction of end-stage renal disease.
    Roy L; White-Guay B; Dorais M; Dragomir A; Lessard M; Perreault S
    Kidney Int; 2013 Sep; 84(3):570-7. PubMed ID: 23698228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
    Hertz RP; Unger AN; Lustik MB
    Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underweight Increases the Risk of End-Stage Renal Diseases for Type 2 Diabetes in Korean Population: Data From the National Health Insurance Service Health Checkups 2009-2017.
    Kim YH; Kang JG; Lee SJ; Han KD; Ihm SH; Cho KH; Park YG
    Diabetes Care; 2020 May; 43(5):1118-1125. PubMed ID: 32188773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Retinal Vein Occlusion Following End-Stage Renal Disease.
    Chang YS; Weng SF; Chang C; Wang JJ; Tseng SH; Wang JY; Jan RL
    Medicine (Baltimore); 2016 Apr; 95(16):e3474. PubMed ID: 27100450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of progression from newly diagnosed systemic lupus erythematosus to end stage renal disease and all-cause mortality: a nationwide cohort study in Taiwan.
    Lin WH; Guo CY; Wang WM; Yang DC; Kuo TH; Liu MF; Wang MC
    Int J Rheum Dis; 2013 Dec; 16(6):747-53. PubMed ID: 24382283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of corneal ulcer in patients with end-stage renal disease: a retrospective large-scale cohort study.
    Jan RL; Tai MC; Weng SF; Chang C; Wang JJ; Chang YS
    Br J Ophthalmol; 2018 Jul; 102(7):868-872. PubMed ID: 28855193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bidirectional association between ESRD dialysis and diabetes: National cohort study.
    Chu YW; Wu WS; Hsu CF; Wang JJ; Weng SF; Chien CC
    PLoS One; 2017; 12(3):e0173785. PubMed ID: 28296932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe hypoglycemia and the risk of end stage renal disease in type 2 diabetes.
    Yun JS; Park YM; Han K; Kim HW; Cha SA; Ahn YB; Ko SH
    Sci Rep; 2021 Feb; 11(1):4305. PubMed ID: 33619302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. End Stage Renal Disease as a Potential Risk Factor for Retinal Vein Occlusion.
    Chen SN; Yang TC; Lin JT; Lian IB
    Medicine (Baltimore); 2015 Nov; 94(47):e1960. PubMed ID: 26632690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compliance and persistence with concomitant statin and oral antihyperglycemic therapy.
    Zhang Q; Zhao C; Davies MJ; Radican L; Seck T
    Am J Manag Care; 2011 Nov; 17(11):746-52. PubMed ID: 22084894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.